Search Results - "Overbeek, J. A."

Refine Results
  1. 1

    Long-term persistence with anti-osteoporosis drugs after fracture by Klop, C., Welsing, P. M. J., Elders, P. J. M., Overbeek, J. A., Souverein, P. C., Burden, A. M., van Onzenoort, H. A. W., Leufkens, H. G. M., Bijlsma, J. W. J., de Vries, F.

    Published in Osteoporosis international (01-06-2015)
    “…Summary Long-term persistence with anti-osteoporosis drugs and determinants for discontinuation among fracture patients were examined. Persistence was 75.0 and…”
    Get full text
    Journal Article
  2. 2

    Which long-acting bronchodilator is most cost-effective for the treatment of COPD? by HOOGENDOORN, M, KAPPELHOFF, B. S, OVERBEEK, J. A, WOUTERS, E. F. M, RUTTEN-VAN MÖLKEN, M. P. M. H

    Published in Netherlands journal of medicine (01-10-2012)
    “…The aim of this study was to estimate the cost-effectiveness of tiotropium versus salmeterol to inform decision making within the Dutch healthcare setting. A…”
    Get full text
    Journal Article
  3. 3

    Association between use of antidepressants or benzodiazepines and the risk of subsequent fracture among those aged 65+ in the Netherlands by van de Ven, L. I., Klop, C., Overbeek, J. A., de Vries, F., Burden, A. M., Janssen, P. K.

    Published in Osteoporosis international (01-11-2018)
    “…Summary This is the first study to examine the association between antidepressant and benzodiazepine use following a MOF and risk of subsequent fracture in…”
    Get full text
    Journal Article
  4. 4

    All-cause mortality with current and past use of antidepressants or benzodiazepines after major osteoporotic and hip fracture by de Bruin, I. J. A., Klop, C., Wyers, C. E., Overbeek, J. A., Geusens, P. P. M. M., van den Bergh, J. P. W., Driessen, J. H. M., de Vries, F.

    Published in Osteoporosis international (01-03-2019)
    “…Summary In the first year, after an osteoporotic fracture of a hip, forearm, upper arm, or spine, the dispensing rates of antidepressants and benzodiazepines…”
    Get full text
    Journal Article
  5. 5

    Long term trends in oral antidiabetic drug use among children and adolescents in the Netherlands by Fazeli Farsani, S., Souverein, P. C., Overbeek, J. A., Vorst, M. M. J., Knibbe, C. A. J., Herings, R. M. C., Boer, A., Mantel‐Teeuwisse, A. K.

    Published in British journal of clinical pharmacology (01-08-2015)
    “…Aim The aim of the study was to document long term trends in oral antidiabetic drug (OAD) use among children and adolescents in the Netherlands. Methods A…”
    Get full text
    Journal Article
  6. 6

    Chemotherapy for ovarian cancer in the Netherlands: a population-based study on treatment patterns and outcomes by Houben, E., van Haalen, H. G. M., Sparreboom, W., Overbeek, J. A., Ezendam, N. P. M., Pijnenborg, J. M. A., Severens, J. L., van Herk-Sukel, M. P. P.

    “…Information on treatment patterns for ovarian cancer (OC) is limited. The aim of this study was to describe current patterns of chemotherapy and other systemic…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Increased Prevalence of Diabetes In The Netherlands Is Only Partly Explained By Changes In Age And Sex Over Time by Overbeek, JA, van der Heijden, AA, Herings, RM, Nijpels, G

    Published in Value in health (01-10-2017)
    “…OBJECTIVES: Different West-European countries have observed a rise in the prevalence of type 2 diabetes during the last decade. As the Dutch population is…”
    Get full text
    Journal Article
  16. 16

    Real-world data of HER2-low metastatic breast cancer: A population based cohort study by Holthuis, Emily I., Vondeling, Gerard T., Kuiper, Josephina G., Dezentjé, Vincent, Rosenlund, Mats, Overbeek, Jetty A., van Deurzen, Carolien H.M.

    Published in Breast (Edinburgh) (01-12-2022)
    “…With the introduction of investigational human epidermal growth factor receptor 2 (HER2) targeting treatments, thorough understanding of breast cancer with…”
    Get full text
    Journal Article
  17. 17

    Factors Associated with Type 2 Diabetes Mellitus Treatment Choice Across Four European Countries by Heintjes, Edith M., Overbeek, Jetty A., Hall, Gillian C., Prieto-Alhambra, Daniel, Lapi, Francesco, Hammar, Niklas, Bezemer, Irene D.

    Published in Clinical therapeutics (01-11-2017)
    “…The aim of this analysis was to identify factors associated with the choice of type 2 diabetes mellitus (T2DM) therapy at the time of intensification of…”
    Get full text
    Journal Article
  18. 18

    Type 2 Diabetes, the Epidemic: Trends in Prevalence and Incidence, 2004-2020 by Overbeek, Jetty A, Nijpels, Giel, Swart, Karin M A, Blom, Marieke T, Elders, Petra J M, Herings, Ron M C

    Published in Diabetes, metabolic syndrome and obesity (01-01-2024)
    “…Only a few studies reported the incidence of type 2 diabetes (T2D). Understanding recent trends in diabetes is vital for planning future diabetes care. This…”
    Get full text
    Journal Article
  19. 19

    Completeness and Representativeness of the PHARMO General Practitioner (GP) Data: A Comparison with National Statistics by Overbeek, Jetty A, Swart, Karin M A, Houben, Eline, Penning-van Beest, Fernie J A, Herings, Ron M C

    Published in Clinical epidemiology (01-01-2023)
    “…When using incomplete or non-representative real-world data (RWD), bias is more likely to occur. The aim of the current study was to assess the completeness…”
    Get full text
    Journal Article
  20. 20